Citation Impact
Citing Papers
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
2007 Standout
Outcome of Pulmonary Vascular Disease in Pregnancy: A Systematic Overview From 1978 Through 1996
1998
End-tidal Pco 2 Abnormality and Exercise Limitation in Patients With Primary Pulmonary Hypertension
2005
Primary Pulmonary Hypertension
2000
Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension
2003
The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension
1999
Brain Natriuretic Peptide as Noninvasive Marker of the Severity of Right Ventricular Dysfunction in Chronic Thromboembolic Pulmonary Hypertension
2007
Treatment of Pulmonary Arterial Hypertension
2004 Standout
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
Atrial septostomy improves survival in select patients with pulmonary hypertension
2007
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
2010 Standout
Clinical significance of brain natriuretic peptide in primary pulmonary hypertension
2004
Antithrombotic Therapy for VTE Disease
2016 Standout
A global view of pulmonary hypertension
2016 Standout
Exercise Standards for Testing and Training
2013 Standout
Rare diseases bullet 5: Primary pulmonary hypertension
1999
A USA-based registry for pulmonary arterial hypertension: 1982–2006
2007
Primary pulmonary hypertension: Current therapy
2002
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Pulmonary Arterial Hypertension in Systemic Sclerosis
2004
Clinical Insights Into the Pathogenesis of Primary Pulmonary Hypertension
1998
Primary Pulmonary Hypertension
1997 Standout
LUNG TRANSPLANTATION FOR PRIMARY PULMONARY HYPERTENSION
2001
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
The Short-term Effects of Digoxin in Patients With Right Ventricular Dysfunction From Pulmonary Hypertension
1998
Diagnosis and differential assessment of pulmonary arterial hypertension
2004
Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension
1998
Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults
2014
Free Fatty Acid Kinetics and Oxidation in Congestive Heart Failure
1998
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
2001 Standout
Big Endothelin-1 and Endothelin-1 Plasma Levels Are Correlated With the Severity of Primary Pulmonary Hypertension
2001
Pulmonary Hypertension Associated with Left-Sided Heart Disease
2007
Bosentan Therapy for Pulmonary Arterial Hypertension
2002 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
American Society of Echocardiography Recommendations for Performance, Interpretation, and Application of Stress Echocardiography
2007
Impact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 Rats
2016
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
The endothelin system in pulmonary arterial hypertension
2004
Prognosis of Pulmonary Arterial Hypertension*
2004
Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension
2006
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
2004
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Introduction
2004
Brain Natriuretic Peptide and Exercise Capacity in Lung Fibrosis and Pulmonary Hypertension
2004
Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension
2000
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension
2002 Standout
Pulmonary Arterial Hypertension in France
2006 Standout
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1
2013 StandoutNobel
Blade Balloon Atrial Septostomy in Patients With Severe Primary Pulmonary Hypertension
1995
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.
2007 StandoutNobel
Pulmonary Arterial Hypertension
2006
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
2002 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Right Ventricular Function in Cardiovascular Disease, Part II
2008
Endothelin Receptor Blockers in Cardiovascular Disease
2003
Hemodynamic Effects of Bosentan, an Endothelin Receptor Antagonist, in Patients With Pulmonary Hypertension
2000
EndothelinB receptor‐mediated contraction in human pulmonary resistance arteries
1996
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Hemodynamic and Clinical Correlates of Endothelin-1 in Chronic Thromboembolic Pulmonary Hypertension
2006
Diagnosis and Treatment of Secondary (Non–Category 1) Pulmonary Hypertension
2008
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Increased Brain Natriuretic Peptide as a Marker for Right Ventricular Dysfunction in Acute Pulmonary Embolism
2001
Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension
2008
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Abnormalities of Neurohormonal and Cardiac Autonomic Nervous Activities Relate Poorly to Functional Status in Fontan Patients
2004
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
2000
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Assessment of Survival in Patients With Primary Pulmonary Hypertension
2002
Works of Mark Nootens being referenced
Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension
1995
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels
1995
Comparative Acute Effects of Adenosine and Prostacyclin in Primary Pulmonary Hypertension
1995
Successful management of labor and delivery in primary pulmonary hypertension
1993
The Prevalence and Significance of a Patent Foramen Ovale in Pulmonary Hypertension
1993
Short-term effectiveness of nifedipine in secondary pulmonary hypertension
1993
Timing of single lung transplantation for primary pulmonary hypertension.
1994